- The folks at Thomas Jefferson University are studying the effects of IV/oral n-acetylcysteine on Post Biopsy, Stage 0/1 Breast Cancer and Pre-surgery in females ages 18 years and older. This clinical trial is slated to start July 2012 and is expected to end circa December 2016.
This study is officially titled, "Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer."
|Recruiting||Jefferson Myrna Brind Center for Integrative Medicine|
Philadelphia, Pennsylvania, 19107
United States - map
|Michael J Matthews||215-629-6146|
For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.